FDA warns doctors to beware fake drug distributors

Published



WASHINGTON (AP) — U.S. health regulators are trying to help doctors spot counterfeit and unapproved drugs by raising awareness of illegal operations that peddle bogus drugs to health professionals.

Federal prosecutors have recently uncovered rogue companies distributing foreign versions of Botox, fake cancer drugs and other unapproved or contaminated medicines in the U.S. Often those operations will entice physicians by faxing “too good to be true” flyers that offer 75 percent or more off pricey injectable drugs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.